Stan Lightfoot
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 8
- Retinoids in leukemia and cellular processes 7
- Oncology 27
- Pancreatic and Hepatic Oncology Research 14
- Co-authors
- Chinthalapally V. Rao (48 shared papers)Altaf Mohammed (41 shared papers)Megan R. Lerner (29 shared papers)Daniel J. Brackett (25 shared papers)Naveena B. Janakiram (23 shared papers)Courtney W. Houchen (11 shared papers)Randal May (11 shared papers)Vernon E. Steele (26 shared papers)
- Journals
- Cancer Research (17 papers)Cancer Prevention Research (11 papers)Cancer Investigation (6 papers)Oncotarget (4 papers)Neoplasia (4 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Stan Lightfoot
109 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 607
- Oncology 965
- Molecular Biology 1.6k
- Immunology 243
- Biotechnology 106
Countries citing papers authored by Stan Lightfoot
This map shows the geographic impact of Stan Lightfoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Lightfoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Lightfoot more than expected).
Fields of papers citing papers by Stan Lightfoot
This network shows the impact of papers produced by Stan Lightfoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Lightfoot. The network helps show where Stan Lightfoot may publish in the future.
Co-authors
The 25 scholars most cited alongside Stan Lightfoot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 178 | |
| 2 | 2009 | 141 | |
| 3 | 2011 | 135 | |
| 4 | 2013 | 133 | |
| 5 | 2013 | 122 | |
| 6 | 2012 | 109 | |
| 7 | 2006 | 100 | |
| 8 | 2005 | 96 | |
| 9 | 2016 | 83 | |
| 10 | 2014 | 70 | |
| 11 | 2012 | 69 | |
| 12 | 2013 | 61 | |
| 13 | Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro. | 2002 | 60 |
| 14 | 2008 | 60 | |
| 15 | 2010 | 60 | |
| 16 | 2011 | 59 | |
| 17 | 2014 | 56 | |
| 18 | 2015 | 56 | |
| 19 | 2005 | 54 | |
| 20 | 2017 | 50 |
About Stan Lightfoot
Stan Lightfoot is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Genetics, having authored 109 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer, Lipids, and Metabolism (11 papers), Estrogen and related hormone effects (9 papers), Epigenetics and DNA Methylation (8 papers), Retinoids in leukemia and cellular processes (7 papers), Cancer Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Inflammatory mediators and NSAID effects (7 papers). The work is most often cited by research in Cancer Research (607 citations), Oncology (965 citations), Molecular Biology (1.6k citations), Immunology (243 citations) and Biotechnology (106 citations). Stan Lightfoot has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Chinthalapally V. Rao, Altaf Mohammed, Megan R. Lerner, Daniel J. Brackett, Naveena B. Janakiram, Courtney W. Houchen, Randal May, Vernon E. Steele, Russell G. Postier and Sripathi M. Sureban. Their work appears in journals such as Cancer Research, Cancer Prevention Research, Cancer Investigation, Oncotarget and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.